Wai Chun Bio-Technology Faces Widening Annual Losses

Wai Chun Bio-Technology Ltd. (HK:0660) has released an update.

Wai Chun Bio-Technology Ltd. reported a significant increase in losses for the year ending June 30, 2024, with a net loss of HK$65.7 million compared to HK$10.1 million the previous year. The company’s revenue nearly halved, while it faced impairment losses on property, plant, and equipment, adding to its financial woes. Investors may find the widening losses and reduced revenue figures concerning as they reflect potential challenges in the company’s operational performance.

For further insights into HK:0660 stock, check out TipRanks’ Stock Analysis page.